Skip to main content

Assessing the Reporting of Adherence and Sexual Activity in a Simulated Microbicide Trial in South Africa: An Interview Mode Experiment Using a Placebo Gel

Abstract

Misreporting of adherence undermines detection of an association between product use and HIV infection in microbicide trials. This study investigates whether, in a placebo trial, audio computer-assisted self-interviewing (ACASI) produces more accurate reporting of adherence and sexual behavior than a face-to-face interview (FTFI). At three South African clinics, 849 women were enrolled and instructed to use applicators filled with placebo gel; participants were randomly assigned to FTFI or ACASI. Behavioral reports were validated through two biomarkers that detect product usage and unprotected sex. For most behaviors, ACASI generated significantly higher reporting, although differences by interview mode appeared to diminish over time. ACASI participants were more likely to report having had sex without gel, but reported and tested applicators did not indicate greater honesty about gel insertion with ACASI. While comparisons of reported unprotected sex with the validated biomarker revealed more agreement with ACASI than with FTFI, differences were small.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. UNAIDS. Sub-Saharan Africa: AIDS epidemic update regional summary. Geneva: UNAIDS and World Health Organization; 2008.

    Google Scholar 

  2. Bongaarts J, Buettner T, Heilig G, Pelletier F. Has the HIV epidemic peaked? Popul Dev Rev. 2008;34(2):199–224.

    Article  Google Scholar 

  3. Padian NS, Buvé A, Balkus J, Serwadda D, Cates W Jr. HIV prevention 2: biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet. 2008;372(9638):585–99.

    CAS  Article  PubMed  Google Scholar 

  4. Karim QA, Karim SSA, Frohlich JA, et al. Effectiveness and safety of Tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.

    Article  Google Scholar 

  5. Feldblum PJ, Adeiga A, Bakare R, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS ONE. 2008;3(1):e1474. PMID: 18213382.

    Article  PubMed  Google Scholar 

  6. Peterson L, Nanda K, Opoku BK, et al. SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS ONE. 2007;2(12):e1312.

    Article  PubMed  Google Scholar 

  7. Stirratt MJ, Gordon CM. Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research. Curr HIV/AIDS Rep. 2008;5:186–92.

    Article  PubMed  Google Scholar 

  8. Stone A, Jiang S. Microbicides: stopping HIV at the gate. Lancet. 2006;368(9534):431–3.

    Article  PubMed  Google Scholar 

  9. Tolley EE, Harrison PF, Goetghebeur E, et al. Adherence and its measurement in phase 2/3 microbicide trials. AIDS Behav. 2009. doi:10.1007/s10461-009-9635-x.

  10. Trussell J, Dominik R. Will microbicide trials yield unbiased estimates of microbicide efficacy? Contraception. 2005;72(6):408–13.

    CAS  Article  PubMed  Google Scholar 

  11. Turner AN, De Kock AE, Meehan-Ritter A, et al. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews. J Clin Epidemiol. 2009;62(7):759–65.

    Article  PubMed  Google Scholar 

  12. Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977–87.

    CAS  Article  PubMed  Google Scholar 

  13. Institute of Medicine of the National Academies Committee on the Methodological Challenges in HIV Prevention Trials. Methodological challenges in biomedical HIV prevention trials. Washington, DC: Institute of Medicine, National Academies Press; 2008.

    Google Scholar 

  14. Weiss HA, Wasserheit JN, Barnabas RV, Hayes RJ, Abu-Raddad LJ. Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol. 2008;5:8.

    Article  PubMed  Google Scholar 

  15. van de Wijgert J, Padian N, Shiboski S, Turner C. Is audio computer-assisted self-interviewing a feasible method of surveying in Zimbabwe. Int J Epidemiol. 2000;29:885–90.

    Article  PubMed  Google Scholar 

  16. Lara D, Strickler J, Olavarrieta CD, Ellertson C. Measuring induced abortion in Mexico. Sociol Methods Res. 2004;32(4):1–30.

    Article  Google Scholar 

  17. Hewett PC, Erulkar AC, Mensch BS. The feasibility of computer-assisted survey interviewing in Africa: experience from two rural districts in Kenya. Soc Sci Comput Rev. 2004;22(3):319–34.

    Article  Google Scholar 

  18. Mensch BS, Hewett PC, Gregory R, Helleringer S. Sexual behavior and STI/HIV status among adolescents in rural Malawi: an evaluation of the effect of interview mode on reporting. Stud Fam Plann. 2008;39(4):321–34. PMC:2670342.

    Article  PubMed  Google Scholar 

  19. Hewett PC, Mensch BS, Erulkar AS. Consistency in the reporting of sexual behaviour by adolescent girls in Kenya: a comparison of interviewing methods. Sex Transm Infect. 2004;80(Suppl II):ii43–8.

    Article  PubMed  Google Scholar 

  20. Mensch BS, Hewett PC, Jones HE, et al. Consistency in women’s reports of sensitive behavior within an interview mode experiment, São Paulo, Brazil. Int Fam Plan Perspect. 2008;34(4):169–76. PMC: 2723120.

    Article  PubMed  Google Scholar 

  21. Potdar R, Koenig MA. Does audio-CASI improve reports of risky behavior? Evidence from a randomized field trial among young urban men in India. Stud Fam Plann. 2005;36(2):107–16.

    Article  PubMed  Google Scholar 

  22. Minnis AM, Muchini A, Shiboski S, et al. Audio computer-assisted self-interviewing in reproductive health research: reliability assessment among women in Harare, Zimbabwe. Contraception. 2007;75(1):59–65.

    Article  PubMed  Google Scholar 

  23. Le LC, Blum RW, Magnani R, Hewett PC, Do HM. A pilot of audio-computer assisted self-interview for youth reproductive health research in Vietnam. J Adolesc Health. 2006;38(6):740–7.

    Article  PubMed  Google Scholar 

  24. van der Elst EM, Okuku HS, Nakamya P, et al. Is audio computer-assisted self-interview (ACASI) useful in risk behaviour assessment of female and male sex workers, Mombasa, Kenya? PLoS ONE. 2009;4(5):e5340.

    Article  PubMed  Google Scholar 

  25. Minnis AM, Steiner MJ, Gallo MF, et al. Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol. 2009;170:918–24.

    Article  PubMed  Google Scholar 

  26. Hewett PC, Mensch BS, Ribeiro MCSdA, et al. Using sexually transmitted infection (STI) biomarkers to validate the reporting of sexual behavior within a randomized, experimental evaluation of interviewing methods. Am J Epidemiol. 2008;168(2):202–11.

    Article  PubMed  Google Scholar 

  27. Wallace A, Thorn M, Maguire RA, Sudol KM, Phillips DM. Assay for establishing whether microbicide applicators have been exposed to the vagina. Sex Transm Dis. 2004;31(8):465–8.

    Article  PubMed  Google Scholar 

  28. Wallace AR, Teitelbaum A, Wan L, et al. Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials. Contraception. 2007;76:53–6.

    Article  PubMed  Google Scholar 

  29. Mauck C, Weiner DH, Ballagh S, et al. Single and multiple exposure tolerance study of cellulose sulfate gel: a phase I safety and colposcopy study. Contraception. 2001;64(6):383–91.

    CAS  Article  PubMed  Google Scholar 

  30. Mauck CK. Biomarkers of semen exposure. Sex Transm Dis. 2009;36(3, Supplement):S81–3.

    PubMed  Google Scholar 

  31. Mâsse BR, Boily MC, Dimitrov D, Desai K. Efficacy dilution in randomized placebo-controlled vaginal microbicide trials. Emerg Themes Epidemiol. 2009;6:5.

    Article  PubMed  Google Scholar 

  32. Tolley EE, Severy LJ. Integrating behavioral and social science research into microbicide clincal trials: challenges and opportunities. Am J Public Health. 2006;96(1):79–83.

    Article  PubMed  Google Scholar 

  33. Nunn A, McCormack S, Crook AM, Pool R, Rutterford C, Hayes R. Microbicide development programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009; 10(99). http://www.biomedcentral.com/content/pdf/1745-6215-10-99.pdf.

Download references

Acknowledgments

The authors thank Barbara Friedland, for her assistance in developing this project, for providing guidance, and for her careful reading of the manuscript. We also acknowledge Sumen Govender, Marlena Gehret, Vuyelwa Mehlomakulu, and Robin Maguire for their contributions. Funding for this research was provided by the Office of Population and Reproductive Health, Bureau for Global Health, United States Agency for International Development (USAID) under Award No. GPO-A-00-04-00019, and the William and Flora Hewlett Foundation. The opinions expressed herein are those of the author(s) and do not necessarily reflect the views of the U.S. Agency for International Development.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barbara S. Mensch.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mensch, B.S., Hewett, P.C., Abbott, S. et al. Assessing the Reporting of Adherence and Sexual Activity in a Simulated Microbicide Trial in South Africa: An Interview Mode Experiment Using a Placebo Gel. AIDS Behav 15, 407–421 (2011). https://doi.org/10.1007/s10461-010-9791-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-010-9791-z

Keywords

  • ACASI
  • Adherence
  • Biomarkers
  • Microbicides
  • Sexual activity